This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, Z. H. Articles by Shibata, D. Search for Related Content PubMed PubMed Citation Articles by Li, Z. H. Articles by Shibata, D.

American Journal of Pathology, Vol 144, 303-309, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung

ZH Li, J Zheng, LM Weiss and D Shibata
Department of Pathology, USC School of Medicine, Los Angeles 90033.

The topographical distribution of a mutation provides insight into past patterns of tumor evolution. This approach was applied to two loci commonly mutated in adenocarcinoma of the lung--p53 and c-K-ras. In 41 primary adenocarcinomas, c-K-ras codon 12 point mutations were detected in 8 (19.5%) tumors and p53 point mutations were detected in 10 (24.4%) tumors, with one tumor harboring both mutations. These mutations were only detected in malignant cells and with a homogeneous topographical distribution throughout 16 tumors, including metastasis. Intratumor heterogeneity was detected in only one tumor in which a small portion lacked the specific p53 mutation. Based on this topographical analysis, it is likely that when these mutations occur in adenocarcinoma of the lung, they are usually acquired during the very earliest phases of tumor formation before the bulk of clonal expansion, and in very small precursor lesions.

This article has been cited by other articles:

				F.R. Hirsch, D.T. Merrick, and W.A. Franklin Role of biomarkers for early detection of lung cancer and chemoprevention Eur. Respir. J., June 1, 2002; 19(6): 1151 - 1158. [Abstract] [Full Text] [PDF]

				J. R.M. van der Sijp, J. P.A.M. van Meerbeeck, A. P.W.M. Maat, P. E. Zondervan, H. F.B.M. Sleddens, A. N. van Geel, A. M.M. Eggermont, and W. N.M. Dinjens Determination of the Molecular Relationship Between Multiple Tumors Within One Patient Is of Clinical Importance J. Clin. Oncol., February 15, 2002; 20(4): 1105 - 1114. [Abstract] [Full Text] [PDF]

				F. R. Hirsch, W. A. Franklin, A. F. Gazdar, and P. A. Bunn Jr. Early Detection of Lung Cancer: Clinical Perspectives of Recent Advances in Biology and Radiology Clin. Cancer Res., January 1, 2001; 7(1): 5 - 22. [Abstract] [Full Text]

				Y. Yatabe, H. Konishi, T. Mitsudomi, S. Nakamura, and T. Takahashi Topographical Distributions of Allelic Loss in Individual Non-Small-Cell Lung Cancers Am. J. Pathol., September 1, 2000; 157(3): 985 - 993. [Abstract] [Full Text] [PDF]

				W. N. ROM, J. G. HAY, T. C. LEE, Y. JIANG, and K.-M. TCHOU-WONG Molecular and Genetic Aspects of Lung Cancer Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1355 - 1367. [Full Text]

				K. M. Fong, Y. Sekido, and J. D. Minna MOLECULAR PATHOGENESIS OF LUNG CANCER J. Thorac. Cardiovasc. Surg., December 1, 1999; 118(6): 1136 - 1152. [Abstract] [Full Text] [PDF]

				K. M. Gressani, S. Leone-Kabler, M.G. O'Sullivan, L.D. Case, A. M. Malkinson, and M. S. Miller Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene Carcinogenesis, November 1, 1999; 20(11): 2159 - 2165. [Abstract] [Full Text] [PDF]

				S. E. Shackney, C. A. Smith, A. Pollice, M. Levitt, J. A. Magovern, R. J. Wiechmann, J. Silverman, L. Sweeney, and R. J. Landreneau GENETIC EVOLUTIONARY STAGING OF EARLY NON-SMALL CELL LUNG CANCER: THE P53 -> HER-2/NEU -> ras SEQUENCE J. Thorac. Cardiovasc. Surg., August 1, 1999; 118(2): 259 - 269. [Abstract] [Full Text] [PDF]

				T. Kohno and J. Yokota1 How many tumor suppressor genes are involved in human lung carcinogenesis? Carcinogenesis, August 1, 1999; 20(8): 1403 - 1410. [Abstract] [Full Text] [PDF]

				A. S. Tam, J. F. Foley, T. R. Devereux, R. R. Maronpot, and T. E. Massey High Frequency and Heterogeneous Distribution of p53 Mutations in Aflatoxin B1-induced Mouse Lung Tumors Cancer Res., August 1, 1999; 59(15): 3634 - 3640. [Abstract] [Full Text] [PDF]

				M. C. Tammemagi, J. R. McLaughlin, and S. B. Bull Meta-Analyses of p53 Tumor Suppressor Gene Alterations and Clinicopathological Features in Resected Lung Cancers Cancer Epidemiol. Biomarkers Prev., July 1, 1999; 8(7): 625 - 634. [Abstract] [Full Text]

				M. Shoji, Y. Dobashi, S. Morinaga, S.-X. Jiang, and T. Kameya Tumor Extension and Cell Proliferation in Adenocarcinomas of the Lung Am. J. Pathol., March 1, 1999; 154(3): 909 - 918. [Abstract] [Full Text] [PDF]

				V. A. M. C. Somers, D. A. Leimbach, P. H. M. H. Theunissen, J. J. Murtagh Jr., B. Holloway, A. W. Ambergen, and F. B. J. M. Thunnissen Validation of the Point-EXACCT method in non-small cell lung carcinomas Clin. Chem., July 1, 1998; 44(7): 1404 - 1409. [Abstract] [Full Text] [PDF]